SOLARVEST BIOENER
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of… Read more
SOLARVEST BIOENER (0ZJ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SOLARVEST BIOENER (0ZJ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SOLARVEST BIOENER - Net Assets Trend (None–None)
This chart illustrates how SOLARVEST BIOENER's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SOLARVEST BIOENER (None–None)
The table below shows the annual net assets of SOLARVEST BIOENER from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SOLARVEST BIOENER's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SOLARVEST BIOENER Competitors by Market Cap
The table below lists competitors of SOLARVEST BIOENER ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Metalyst Forgings Limited
NSE:METALFORGE
|
$766.45K |
|
LATTICE SEMICONDUCT
MU:LTT
|
$766.76K |
|
Hepion Pharmaceuticals Inc
NASDAQ:HEPA
|
$766.94K |
|
B2digital Inc
PINK:BTDG
|
$767.23K |
|
Groupe Bruxelles Lambert SA
MU:EAI
|
$765.58K |
|
Sabre Resources Limited
F:SAL
|
$765.57K |
|
DTCOM - Direct to Company S.A
SA:DTCY3
|
$765.33K |
|
Trinity Bank National Assocation
PINK:TYBT
|
$765.09K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SOLARVEST BIOENER's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SOLARVEST BIOENER's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SOLARVEST BIOENER utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SOLARVEST BIOENER's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SOLARVEST BIOENER (0ZJ) | €- | N/A | N/A | $766.41K |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |